Previous close | 21.09 |
Open | 21.09 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 21.09 - 21.09 |
52-week range | 14.02 - 22.00 |
Volume | |
Avg. volume | 75 |
Market cap | 6.787B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 23.18 |
EPS (TTM) | 0.91 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
As you might know, Exelixis, Inc. ( NASDAQ:EXEL ) last week released its latest quarterly, and things did not turn out...
ALAMEDA, Calif., April 30, 2024--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated commercial, clinical and pipeline development milestones.
Key Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive to their trading...